Literature DB >> 24825089

Symptomatic cerebral infarction in a child with severe diabetic ketoacidosis.

Ayla Güven, Suna Hancili, Elif Y Karatoprak, Bülent Tasel.   

Abstract

BACKGROUND: Diabetic ketoacidosis (DKA) is a common initial presentation of pediatric type 1 diabetes mellitus. Intracerebral complications of DKA pose significant mortality and morbidity rates.
OBJECTIVE: Our aim is to emphasize the importance of early identification, investigation, and treatment for patients who present with DKA and stroke. CASE REPORT: Here, we report a case of a 4-year-old female patient who presented with ischemic-hemorrhagic stroke as a complication of DKA.
CONCLUSION: Cerebrovascular complications of DKA in children are a rare condition; however, higher risks take place in their youngest age. Clinicians should be aware of these complications so as to develop appropriate approach for its management.

Entities:  

Mesh:

Year:  2014        PMID: 24825089     DOI: 10.1515/jpem-2014-0037

Source DB:  PubMed          Journal:  J Pediatr Endocrinol Metab        ISSN: 0334-018X            Impact factor:   1.634


  3 in total

1.  Overexpression of lncRNA ANRIL up-regulates VEGF expression and promotes angiogenesis of diabetes mellitus combined with cerebral infarction by activating NF-κB signaling pathway in a rat model.

Authors:  Bo Zhang; Dan Wang; Tie-Feng Ji; Lei Shi; Jin-Lu Yu
Journal:  Oncotarget       Date:  2017-03-07

2.  Ischaemic Haemorrhagic Stroke in a Child with New Onset Type 1 Diabetes Mellitus.

Authors:  Noor Shafina Mohd Nor; Choong Yi Fong; Kartini Rahmat; Wan Mun Vanessa Lee; Azriyanti Anuar Zaini; Muhammad Yazid Jalaludin
Journal:  Eur Endocrinol       Date:  2018-04-18

3.  Homocysteine, interleukin-1β, and fasting blood glucose levels as prognostic markers for diabetes mellitus complicated with cerebral infarction and correlated with carotid intima-media thickness.

Authors:  Zhenxiang Dai; Yang Jiao; Qingxian Fan; Anning Qi; Liang Xiao; Jingwei Li
Journal:  Exp Ther Med       Date:  2019-12-13       Impact factor: 2.447

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.